Diseases Industry Analysis

Reportbuyer.com helps you stay ahead with advanced reports on Diseases. Information includes Competitive Positioning, Stakeholder Opinions and Future Market Watch.

Your filters clear all
None selected
clear

Discounts and Delivery

clear

Price

Change currency
EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023 (GDA100000)
EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023SummaryAllergic rhinitis is a chronic respiratory disease characterized by inflammation of the nasal cavity and affects people of all ages. The main...
Apr 2014£2,480€2,942$3,995
Vital Signs - Healthcare News - The Analyst%s Perspect March 2014 Issue (FRS04123)
This issue of Vital Signs, released on March 31, 2014, discusses the premium price tag of Gilead's Sovaldi, Sony's genomic partnership with Illumina, and Craig Venter's latest venture, Human Longevity,...
Mar 2014 £0
EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022 (GDA100000)
EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022SummaryAnkylosing spondylitis is a systemic, chronic, and progressive inflammatory arthritis in the family of seronegativespondyloarthritis, and is one of the most common...
Mar 2014£2,480€2,942$3,995
OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017 (GDA100000)
OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017SummaryWith five-year survival only approximately 5%, pancreatic cancer is characterized as a disease with some of the highest unmet need in...
Mar 2014£3,720€4,414$5,995
Physician Views: Life-cycle management strategies in multiple sclerosis - can new versions of Copaxone, Avonex drive market share retention? (FWD00176)
With Copaxone and Avonex generating global sales of $4.3 billion and $3 billion for Teva and Biogen Idec, respectively, in 2013, it is not surprising to see both companies implementing...
Mar 2014£509€604$820
Analytical Tool - Lymphoma (BSK00706)
Executive Summary"Analytical Tool: Lymphoma" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in lymphoma R&D and business development. It is also a map...
Mar 2014£2,615€3,100$4,212
Analytical Tool - Leukemia (BSK00718)
"Analytical Tool - Leukemia" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in leukemia R&D and business development. It is at the same...
Mar 2014£2,615€3,100$4,212
Analytical Tool - Lung Cancer (BSK00712)
Analytical Tool - Lung Cancer is a premium combo product of "Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market" and "Lung Cancer Drug Pipeline...
Mar 2014£2,615€3,100$4,212
Analytical Tool - Prostate Cancer (BSK00765)
"Analytical Tool - Prostate Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in prostate cancer R&D and business development. It is at...
Mar 2014£2,615€3,100$4,212
Analytical Tool - Pancreatic Cancer (BSK00700)
"Analytical Tool - Pancreatic Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in pancreatic cancer R&D and business development. It is at...
Mar 2014£2,615€3,100$4,212
Analytical Tool - Colorectal Cancer (BSK00730)
"Analytical Tool - Colorectal Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in colorectal cancer R&D and business development. It is at...
Mar 2014£2,615€3,100$4,212
Analytical Tool - Breast Cancer (BSK00761)
"Analytical Tool - Breast Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in breast cancer R&D and business development. It is at...
Mar 2014£2,615€3,100$4,212
Analytical Tool - Hematological Cancers (BSK00724)
"Analytical Tool - Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is...
Mar 2014£5,015€5,950$8,078
Zoll Medical Corporation - Strategic SWOT Analysis Review (GDA33314)
Zoll Medical Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information...
Mar 2014£78€93$125
Anavex Life Sciences Corp. (AVXL) - Financial and Strategic SWOT Analysis Review (GDA13521)
Anavex Life Sciences Corp. (AVXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled...
Mar 2014£78€93$125
Non-small cell lung cancer: Game changing immunotherapies to revolutionise treatment - KOL Insight (FWD00175)
Change is coming to the NSCLC treatment algorithm—and it's coming soon. Revolutionary new immunotherapies, more personalised treatment choices and further drug developments are all set to roll out in the...
Mar 2014£3,737€4,433$6,019
Papillary Thyroid Cancer Global Clinical Trials Review, H1, 2014 (GDA100000)
Papillary Thyroid Cancer Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, “Papillary Thyroid Cancer Global Clinical Trials Review, H1, 2014" provides data on the Papillary Thyroid Cancer clinical trial...
Mar 2014£1,550€1,839$2,500
Mertiva AB (MERT MTF) - Financial and Strategic SWOT Analysis Review (GDA100000)
Mertiva AB (MERT MTF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by...
Mar 2014£78€93$125
Deep Brain Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia-Pacific and Latin America) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 (TAN00333)
A rise in the world's aging population, increase in the number of patients living with Parkinson's disease and growing awareness about neurological movement disorders among patients have triggered the growth...
Mar 2014£2,975€3,530$4,795
Global Diabetic Nephropathy Market 2014-2018 (INF03340)
About Diabetic NephropathyDiabetic nephropathy is a disease of the kidney glomerulus, which is caused by high blood sugar. When diabetes damages kidneys, which contain millions of tiny blood vessel...
Mar 2014£1,550€1,839$2,500
NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool (GBI00782)
NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment PoolSummaryGBI Research, the leading business intelligence provider, has released...
Mar 2014£2,175€2,581$3,500
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2014 (GDA100000)
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2014" provides...
Mar 2014£1,550€1,839$2,500
Aqualis ASA (AQUA) - Financial and Strategic SWOT Analysis Review (GDA100000)
Aqualis ASA (AQUA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData...
Mar 2014£78€93$125
Inovio Pharmaceuticals, Inc. (INO) - Financial and Strategic SWOT Analysis Review (GDA04997)
Inovio Pharmaceuticals, Inc. (INO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by...
Mar 2014£78€93$125
GW Pharmaceuticals plc (GWP) - Financial and Strategic SWOT Analysis Review (GDA09083)
GW Pharmaceuticals plc (GWP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by...
Mar 2014£78€93$125